Some group x time effects Foretinib solubility dmso were observed among groups in low-density lipoprotein (LDL) levels (p = 0.005) with LDL levels significantly decreasing after the loading phase in the CrM group. Univariate ANOVA revealed no Selumetinib in vitro significant differences among groups in blood glucose (p = 0.67). Table 10 Serum lipids and glucose Marker N Group Day   p-level       0 7 28     TCHL (mg/dl) 11 KA-L 149.1 ± 25 153.0 ± 23 149.9 ± 28 Group 0.91   12 KA-H 153.3 ± 26 152.3 ± 28 157.5 ± 22 selleckchem Time 0.15   12 CrM 156.3 ± 20 147.3 ± 19 158.9 ± 21 G x T 0.10 HDL (mg/dl) 11 KA-L 48.8 ± 11.3 51.0 ± 9.3 52.9 ± 11.4 Group 0.42   12 KA-H 53.0 ± 16.0 53.9 ± 18.4 53.6 ± 14.4

Time 0.03   12 CrM 45.6 ± 6.5 47.6 ± 7.3 48.5 ± 8.4 G x T 0.64 TCHL: HDL Ratio 11 KA-L 3.16 ± 0.7 3.09 ± 0.6 2.92 ± 0.7 Group 0.34   12 KA-H 3.03 ± 0.6 2.95 ± 0.5 3.04 ± 0.5 Time 0.04   12 CrM 3.48 ± 0.6 3.15 ± 0.6 3.36 ± 0.7 G x T 0.09 LDL 11 KA-L 83.4 ± 16* 86.5 ± 16 81.4 ± 18* Group 0.66 (mg/dl) 12 KA-H 79.4 ± 18* 82.7 ± 19 83.7 ± 16* Time 0.42   12 CrM 89.8 ± 20 81.4 ± 15† 92.5 ± 17 G x T 0.005 TRIG (mg/dl) 11 KA-L 84.5 ± 33 77.3 ± 30 78.5 ± 37 Group 0.20   12 KA-H 105.1 ± 37 78.4 ± 26 101.1 ± 27 Time 0.07   12 CrM 104.1 ± 28 92.1 ± 30 89.6 ± 30 G x T 0.45 Glucose (mg/dl) 11 KA-L 93.0 ± 5.1 90.5 ± 8.2 93.6 ± 4.7 Group 0.44   12 KA-H 91.1 ± 6.6 92.7 ± 8.1 90.4 ± 6.9 Time 0.57   12 CrM 90.5 ± 9.6 89.6 ± 5.5 88.3 ± 6.3 G x T 0.67 Values are means ± standard deviations. Lipid data were analyzed by MANOVA with repeated measures. Greenhouse-Geisser time and group x time (G x T) interaction p-levels are reported with univariate group p-levels. Glucose data were analyzed by repeated measures univariate ANOVA. † represents p < 0.05 difference from baseline. * represents p < 0.05 difference from CrM. Table 11 shows markers of catabolism

and bone status. Overall MANOVA revealed significant time (Wilks’ Lambda p < 0.001) effects with no significant group x time effects (Wilks’ Lambda p = 0.19) in markers of catabolism. Univariate MANOVA found no significant group x time interactions Aprepitant in blood urea nitrogen (BUN, p = 0.75), BUN to creatinine ratio (p = 0.24), aspartate aminotransferase (AST, p = 0.68), alanine aminotransferase (ALT, p = 0.48), total protein (p = 0.84), and total bilirubin (TBIL, p = 0.26). Serum creatinine levels increased in all groups (p < 0.001) over time with a significant group x time interaction demonstrating higher doses of creatine in the CrM and KA-H groups promoting significantly greater increases in serum creatinine (p = 0.03) than the KA-L group.